Molecular Genetic Pathology Fellowship Program

Clinical and Research Training

MGP Fellowship training is a one-year experience. The primary purpose of the MGP fellowship is to train the fellow to become an expert clinical consultant in molecular genetic testing as well as a qualified technical consultant in the choice, development, evaluation and interpretation of clinical assays. This phase of training occupies the majority of the first year during which the fellow is expected to undertake several clinical projects designed to lead to presentable and/or publishable results. The fellow is also exposed heavily to day-to-day management issues associated with running a modern molecular genetic laboratory and should be qualified to direct such a laboratory upon completing the fellowship. The training offered will meet the training requirements of the joint American Board of Pathology - American Board of Medical Genetics Training Program in Molecular Genetic Pathology .

An additional year of training may be available for fellows interested in basic research within or outside the Division of Molecular and Genomic Pathology. Research in the Division includes active basic research programs dealing with mechanisms and mediators of programmed cell death, oxidative mechanisms of pulmonary disease and cell signaling in endocrine and liver neoplasia. There are also ongoing clinical and translational research efforts; these include clinico-pathologic correlations and improved assay method development in genetic and oncologic disorders, quantitative assessment of gene expression, the use of microfabricated chips in diagnostics, and regulatory, economic, ethical, and informatics issues associated with clinical Molecular Genetic Pathology . The Program also interfaces with a number of clinical user groups in the Medical Center, as well as investigators in the University of Pittsburgh Cancer Institute as well as other faculty in the Department of Pathology to support developmental and clinical molecular genetic testing in a variety of cancers. There is a broad array of research opportunities elsewhere in the Department and the medical center to include particular strengths in cell growth, differentiation and regeneration, cancer, gene therapy, genomic sciences and quantitative genetics, neurosciences, immunology and molecular biology.